-The Hindu All measures have been taken to maintain the safe mode of critical systems with skeletal staff at the Kudankulam Nuclear Power Plant in spite of work coming to a halt at the project site following protests, S.S. Bajaj, Chairman, Atomic Energy Regulatory Board (AERB), said on Thursday. Interacting with the media on the sidelines of the 43rd annual conference of the Society of Nuclear Medicine (India), Dr. Bajaj said that...
More »SEARCH RESULT
Research on Bhopal gas victims waits, not drug trials on them by Abantika Ghosh
The Indian Council of Medical Research (ICMR) has posted an advertisement inviting, by December 31, research proposals on long-term effects of methyl isocyanate (MIC) gas on Bhopal’s residents. However, while it is yet to conduct this research 27 years after the Bhopal gas tragedy caused by MIC that left hundreds dead, data shows that the “gas patients” have been routinely used for clinical trials for new drugs at the Bhopal Memorial...
More »Faulty formula by Ankur Paliwal
New drug pricing policy proposes bringing all essential medicines under price control, but makes them expensive After years of dilly-dallying and several Supreme Court reminders, the Centre has proposed to bring all essential drugs under price control. But the policy is nothing but hogwash. Its pricing mechanism would make essential medicines out of reach for most people. Public health experts have termed the draft National Pharmaceutical Pricing Policy of 2011 a...
More »Prices of 348 essential drugs to be controlled
-The Times of India The Centre on Thursday responded to the Supreme Court's concern over spiralling prices of essential medicines and promised to make all-out efforts to put under strict price control regime all the 348 drugs included in the National List of Essential Medicines (NLEM), 2011. A bench comprising Justices G S Singhvi and S J Mukhopadhaya had, in the last hearing, expressed concern over the shrinking list of medicines under...
More »New pharma policy to cap prices of 60% drugs by Namrata Nandakumar & CH Unnikrishnan
India’s new pharmaceutical policy seeks to bring at least 400 essential medicines—or 60% of the drugs sold in the country—under the government’s pricing control. The department of Pharmaceuticals on Friday put out a draft policy, pending since 2005, after a committee prepared a list of essential medicines, laying down new rules governing drug pricing. Currently, the government controls the prices of only 34 essential medicines. The draft says the policy, to be finalized...
More »